Eric M Dube

CHIEF EXECUTIVE OFFICER

Eric M Dube (CHIEF EXECUTIVE OFFICER) filed 8 Form 4 reports in the trailing twelve months (0 purchases, 8 sales), most often in Travere Therapeutics, Inc. (TVTX). The largest single filing was $25.4M of TVTX (399,730 sh across 7 lots, as filed), executed Sep 15.

Add to watchlist

Return, ttmiAverage return per filing, trailing twelve months

–

no purchases on file

Delay-adjustediThe same average, entered at disclosure dates

–

returns measure stock purchases only

Filings, ttm

0 buys · 8 sells

Median delay

–

execution → disclosure

Volume, ttmiDollar value disclosed in the trailing twelve months

$41.3M

shares × price, as filed

Last traded

Sep 17

Filed Sep 17

Median ADV $123.0M across their filed names

Open performance→

Volume by month

Buys $0 Sells $43.2M

Shares × price, as filed · by filing month · past 24 months

Sectors filed on

Healthcare 8 filings

Sector per market data · by filing · past 12 months

Most traded names

TVTX

Travere Therapeutics, Inc. TVTX · 0 buys · 12 sells 12 filings

Recent filings

TVTXSALE Travere Therapeutics, Inc. View filing → $25.4M
399,730 sh across 7 lots
Exec Sep 15
Filed Sep 17 · 9:31 PM ET TVTXSALE Travere Therapeutics, Inc. View filing → $989K
22,500 sh × $43.95
Exec May 6
Filed May 6 · 5:30 PM ET TVTXSALE Travere Therapeutics, Inc. View filing → $2.6M
63,980 sh across 2 lots
Exec Apr 15
Filed Apr 15 · 5:30 PM ET TVTXSALE Travere Therapeutics, Inc. View filing → $1.9M
60,000 sh across 2 lots
Exec Apr 1
Filed Apr 2 · 5:30 PM ET TVTXSALE Travere Therapeutics, Inc. View filing → $1.8M
60,000 sh × $30.10
Exec Feb 20
Filed Feb 24 · 5:30 PM ET TVTXSALE Travere Therapeutics, Inc. View filing → $3.2M
100,087 sh across 2 lots
Exec Feb 3
Filed Feb 3 · 5:30 PM ET TVTXSALE Travere Therapeutics, Inc. View filing → $1.8M
60,000 sh across 2 lots
Exec Jan 23
Filed Jan 27 · 5:30 PM ET TVTXSALE Travere Therapeutics, Inc. View filing → $3.6M
120,000 sh across 2 lots
Exec Oct 28 2025
Filed Oct 30 2025 · 5:30 PM ET More filings →